Skip to main content

NEXGEL, INC.

corporate_fare Company Profile

NEXGEL, INC.

NXGL·NASDAQ·Industrial Applications And Services·CIK 0001468929

Our Company, incorporated in Delaware on January 13, 2009, manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels. These gels are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels, leveraging proprietary manufacturing technologies. It operates as a contract manufacturer, supplying its gels to third parties who integrate them into their own products. Additionally, Our Company offers a line of branded consumer products sold directly to consumers, alongside custom and white label opportunities that combine its gels with proprietary branded products. All gel products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies. These technologies allow for the production of gels meeting rigid tolerance specifications across various physical characteristics, including thickness, water content, adherence, absorption, moisture vapor transmission rate, and release rate, while maintaining product integrity. The company also offers broad choices in liners for gel coating, enabling the determination of tolerances in moisture vapor transmission rate and active ingredient release rates, and personalization of color and texture. In May 2023, Our Company formed CG Converting and Packaging, LLC, a joint venture with CG Laboratories, Inc. located in Granbury, Texas, in which it holds a 50% interest. This joint venture expands its capacity to deliver finished goods to its customer base. As a contract manufacturer, Our Company's hydrogels are currently marketed in the U.S. and abroad by its customers for applications such as Drug Delivery.

NEXGEL, INC. (NASDAQ:NXGL) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 36 items for NXGL at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • NEXGEL Reports Wider Q1 Loss, Reiterates Going Concern, and Discloses Material Control Weaknesses
  • Strategic Partner CEO Invests $1M, Joins Board Amid Nasdaq Deficiency
  • NEXGEL Details New CFO's Compensation and 2025 Executive Pay in Amended 10-K
  • NEXGEL Appoints Experienced CFO Ian Blackman to Lead Financial Strategy and Acquisition Integration
  • Nasdaq Issues Delisting Warning to NEXGEL Over Sub-$1.00 Share Price

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$11.42M
Net Income
-$3M
Diluted EPS
-$0.38
Op. Cash Flow
-$1.31M
Free Cash Flow
-$1.38M
Gross Profit
$4.51M
Operating Income
-$3.35M
Cash & Equivalents
$317K
Debt / Equity
0.00×
Net Margin
-26.3%
Shares Outstanding
8.14M sh
Source: 10-K · filed 2026-04-30 · accession 0001493152-26-020692
$0.1679 -0.01% today
52-week range · as of 2026-09-24 $0.1679 – $2.89
Market cap
$2.15M
Volume
222.9K (0.2× avg)
3-mo avg 1.2M
Live data · 2026-10-05 04:26 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed NXGL - Filings & News (Page 2)

NXGL
May 14, 2026, 5:29 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.5328
Real-time Price: $0.1679 info
Change: -$0.3649 (-68%) info
Market Cap: $2.146M info
NXGL
May 12, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.625
Real-time Price: $0.1679 info
Change: -$0.4571 (-73%) info
Market Cap: $2.146M info
NXGL
Apr 30, 2026, 4:54 PM EDT
Filing Type: 10-K/A
Importance Score:
7
Price at Filing: $0.5902
Real-time Price: $0.1679 info
Change: -$0.4223 (-72%) info
Market Cap: $2.146M info
NXGL
Apr 30, 2026, 4:49 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.5902
Real-time Price: $0.1679 info
Change: -$0.4223 (-72%) info
Market Cap: $2.146M info
NXGL
Apr 24, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.6557
Real-time Price: $0.1679 info
Change: -$0.4878 (-74%) info
Market Cap: $2.146M info
NXGL
Apr 24, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.6557
Real-time Price: $0.1679 info
Change: -$0.4878 (-74%) info
Market Cap: $2.146M info
NXGL
Apr 21, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.6815
Real-time Price: $0.1679 info
Change: -$0.5136 (-75%) info
Market Cap: $2.146M info
NXGL
Apr 21, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.6727
Real-time Price: $0.1679 info
Change: -$0.5048 (-75%) info
Market Cap: $2.146M info
NXGL
Apr 21, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.669
Real-time Price: $0.1679 info
Change: -$0.5011 (-75%) info
Market Cap: $2.146M info
NXGL
Mar 31, 2026, 5:35 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.633
Real-time Price: $0.1679 info
Change: -$0.4651 (-73%) info
Market Cap: $2.146M info
NXGL
Mar 31, 2026, 5:31 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.6595
Real-time Price: $0.1679 info
Change: -$0.4916 (-75%) info
Market Cap: $2.146M info
NXGL
Mar 10, 2026, 9:17 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.08
Real-time Price: $0.1679 info
Change: -$0.9121 (-84%) info
Market Cap: $2.146M info
NXGL
Mar 10, 2026, 8:45 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.40
Real-time Price: $0.1679 info
Change: -$1.23 (-88%) info
Market Cap: $2.146M info
NXGL
Feb 11, 2026, 8:33 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.32
Real-time Price: $0.1679 info
Change: -$1.15 (-87%) info
Market Cap: $2.146M info
NXGL
Feb 10, 2026, 4:13 PM EST
Filing Type: 424B5
Importance Score:
9
Price at Filing: $1.32
Real-time Price: $0.1679 info
Change: -$1.15 (-87%) info
Market Cap: $2.146M info
NXGL
Jan 07, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.72
Real-time Price: $0.1679 info
Change: -$1.55 (-90%) info
Market Cap: $2.146M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets